Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Percutaneous sympathetic blockade in CRPS-1
NL-OMON24168Not yet recruiting
- Sponsor
- Maastricht University Medical Center+
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of bupivacaine in Complex Regional Pain Syndrome Type 1 (CRPS-1), sponsored by Maastricht University Medical Center+. Planned start Apr 2006; status: not yet recruiting.
02
Drugs
bupivacaine
03
Conditions
Complex Regional Pain Syndrome Type 1 (CRPS-1)
Beyond the preview
Go deeper on NL-OMON24168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24168.